Effect of oral gavage dosing regimens in female Tg rasH2 transgenic mice

被引:1
|
作者
Morton, D [1 ]
Sellers, RS [1 ]
Furst, SM [1 ]
Hawley, KD [1 ]
May, JR [1 ]
机构
[1] Pfizer Drug Safety Evaluat, Skokie, IL USA
关键词
carcinogenicity; gavage; mouse; sodium dodecyl sulfate; Tg rasH2; thymus; transgenic;
D O I
10.1080/01926230490457567
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Female Tg rasH2 (CB6F1/Jic-TgrasH2@ Tac) mice were administered water once daily, water twice daily with 8 or 12 hours between doses, 1% sodium dodecyl sulfate in water (1% SDS) once daily, or 1% SDS twice daily with 12 hours between doses by oral gavage at volumes of 10 ml/kg/day for 28 or 29 consecutive days. A control group of mice received no treatment and no sham manipulation. There were no significant differences in body weight or food consumption between treated groups and untreated control mice. Mean weights of spleens, livers, and thymuses were lower than control values in most groups of mice subjected to gavage. Focal or multifocal loss of thymic cortical architecture was observed in 13 of 50 mice distributed among all groups (including naive controls), however only in one instance was this finding suggestive of a precursor to neoplasia. This study demonstrated that Tg rasH2 mice can tolerate once or twice daily gavage dosing with water or vehicle containing 1% SDS. Loss of thymic cortical architecture was a common incidental finding in female Tg rasH2 mice.
引用
收藏
页码:413 / 417
页数:5
相关论文
共 50 条
  • [11] Sensibility of rasH2 and non-Tg mice in two-stage skin carcinogenicity study
    Urano, Koji
    Kawabe, Iviayumi
    Suguro, Mayuko
    Numano, Takamasa
    Yasuda, Masahiko
    Tsutsumi, Hideki
    Furukawa, Fumio
    [J]. TOXICOLOGY LETTERS, 2012, 211 : S55 - S55
  • [12] Exudative Inflammatory Lesions in the Nasal Cavities of the 26-Week Tg.rasH2 Mice Oral Gavage Carcinogenicity Studies
    Paranjpe, Madhav G.
    Belich, Jessica L.
    Richardson, Dayauna R.
    Vidmar, Tom
    Mann, Peter C.
    McKeon, Marie E.
    Elbekai, Reem H.
    Brown, Caren
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2017, 36 (01) : 21 - 28
  • [13] Continuous carcinogenic susceptibility monitoring of CB6F1 TG RASH2 mice
    Urano, K.
    Machida, K.
    Tomizawa, M.
    Ogura, T.
    Nishinaka, E.
    Ito, K.
    Yasuda, M.
    Tsutsumi, H.
    [J]. TOXICOLOGY LETTERS, 2011, 205 : S82 - S83
  • [14] A 28-day oral gavage toxicity study of 3-monochloropropane-1,2-diol (3-MCPD) in CB6F1-non-Tg rasH2 mice
    Lee, Byoung-Seok
    Park, Sang-Jin
    Kim, Yong-Bum
    Han, Ji-Seok
    Jeong, Eun-Ju
    Moon, Kyoung-Sik
    Son, Hwa-Young
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2015, 86 : 95 - 103
  • [15] Lung tumorigenicity in A/J and rasH2 transgenic mice following mainstream tobacco smoke inhalation
    Curtin, GM
    Higuchi, MA
    Ayres, PH
    Swauger, JE
    Mosberg, AT
    [J]. TOXICOLOGICAL SCIENCES, 2004, 81 (01) : 26 - 34
  • [16] Mutation analysis of vinyl carbamate or urethane induced lung tumors in rasH2 transgenic mice
    Tomisawa, M
    Suemizu, H
    Ohnishi, Y
    Maruyama, C
    Urano, K
    Usui, T
    Yasuhara, K
    Tamaoki, N
    Mitsumori, K
    [J]. TOXICOLOGY LETTERS, 2003, 142 (1-2) : 111 - 117
  • [17] Assessment of the Carcinogenic Potential of Pretomanid in Transgenic Tg.rasH2 Mice
    Ambroso, Jeffrey L.
    Dillberger, John
    Bruning-Barry, Rebecca
    Yang, Tian
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2022, 41 (05) : 367 - 379
  • [18] Results from oral gavage carcinogenicity studies of ruxolitinib in Tg.rasH2 mice and Sprague-Dawley (Crl:CD) rats
    Shuey, Dana L.
    Oliver, Julian
    Zhou, Gongfu
    Roberts, Alan
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2016, 81 : 305 - 315
  • [19] The rasH2 transgenic mouse: Nature of the model and mechanistic studies on tumorigenesis
    Tamaoki, N
    [J]. TOXICOLOGIC PATHOLOGY, 2001, 29 : 81 - 89
  • [20] The Tg rasH2 mouse: An alternative to the life time mouse bioassay in pharmaceutical testing
    Morton, D
    Alden, CL
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2000, 19 (06) : 2 - 37